1 | interest | 8,035 |
2 | drainages | 24 |
3 | micropores | 18 |
4 | αpkc | 12 |
5 | 169yb-dtpa | 9 |
6 | c-425 | 9 |
7 | iatrogenesis | 9 |
8 | all-trans-beta-carotene | 8 |
9 | amphenicols | 8 |
10 | ca130 | 8 |
11 | coping-together | 8 |
12 | fraxetin | 8 |
13 | gal-galnac | 8 |
14 | nxf3 | 8 |
15 | tubificidae | 8 |
16 | cyrilovite | 7 |
17 | endoanchors | 7 |
18 | gastrodigenin | 7 |
19 | gsk315234 | 7 |
20 | laevo-ornidazole | 7 |
21 | s-met | 7 |
22 | ¹³co₂ | 7 |
23 | arbovirus | 6 |
24 | crmpk3 | 6 |
25 | cs-1170 | 6 |
26 | fdls | 6 |
27 | lvsd/hf | 6 |
28 | rt002 | 6 |
29 | scorched | 6 |
30 | 113min-dtpa | 5 |
31 | ad5.sstr/tk.rgd | 5 |
32 | cerl2 | 5 |
33 | chimaphilin | 5 |
34 | evp-6124 | 5 |
35 | gdu | 5 |
36 | homogamy | 5 |
37 | hydrocoeles | 5 |
38 | h₂co₃ | 5 |
39 | leeway | 5 |
40 | nondetection | 5 |
41 | paracalcitol | 5 |
42 | plant-parts | 5 |
43 | thapring | 5 |
44 | ves-odt | 5 |
45 | vidofludimus | 5 |
46 | alpha-lithics | 4 |
47 | bettolepsy | 4 |
48 | c2gnt-m | 4 |
49 | control/self-efficacy | 4 |
50 | curassow | 4 |
51 | dip-slides | 4 |
52 | fidelities | 4 |
53 | hampton | 4 |
54 | hypolipidaemics | 4 |
55 | jna-ud-6 | 4 |
56 | l-quebrachitol | 4 |
57 | meaninglessness | 4 |
58 | metacinnabar | 4 |
59 | metallicity | 4 |
60 | monothioarsenate | 4 |
61 | oirsiw | 4 |
62 | pat-sm6 | 4 |
63 | pawr | 4 |
64 | phytosterols/-stanols | 4 |
65 | probiotics/synbiotics | 4 |
66 | psp/lvesv | 4 |
67 | self-processing | 4 |
68 | tamrabhasma | 4 |
69 | trans-1,3-pentadiene | 4 |
70 | trichomonasis | 4 |
71 | tsrds | 4 |
72 | vvgols1 | 4 |
73 | 15-f2alpha-isoprostane | 3 |
74 | 19,731 | 3 |
75 | acra4 | 3 |
76 | advantame | 3 |
77 | allylsilanes | 3 |
78 | arc-welding | 3 |
79 | bereztem | 3 |
80 | bucinnazine | 3 |
81 | capsulodesis | 3 |
82 | cladocroce | 3 |
83 | crf2rs | 3 |
84 | deseases | 3 |
85 | exo-β-1,3-galactanase | 3 |
86 | eyas | 3 |
87 | fluorospectrophotometry | 3 |
88 | gelclair® | 3 |
89 | hydroxylysine | 3 |
90 | inter-est | 3 |
91 | lonipc | 3 |
92 | lpmes | 3 |
93 | ly2886721 | 3 |
94 | megacalycosis | 3 |
95 | metallosis | 3 |
96 | methanofuran | 3 |
97 | micro-colonies | 3 |
98 | msp142 | 3 |
99 | multi-constituent | 3 |
100 | nifeviroc | 3 |
101 | polyphenylene | 3 |
102 | psb28 | 3 |
103 | pyraoxystrobin | 3 |
104 | pyrrolizidines | 3 |
105 | rhil-10 | 3 |
106 | rs2887284 | 3 |
107 | ssa5 | 3 |
108 | tribendimdine | 3 |
109 | txb2/6-k-pgf1alpha | 3 |
110 | uninsurance | 3 |
111 | vpes | 3 |
112 | ≥285 | 3 |
113 | 'trends | 2 |
114 | 10/100,000 | 2 |
115 | 1368insc | 2 |
116 | 18f-fdg-pet | 2 |
117 | 2-bromobenzaldehydes | 2 |
118 | 2.8:1 | 2 |
119 | 200-400nm | 2 |
120 | 3,103 | 2 |
121 | 3,5-dien-1-ynes | 2 |
122 | 3-coumaranones | 2 |
123 | 3-ethoxymethyl-1,4-dihydroquinolin-4-one | 2 |
124 | 4'-hydroxyflurbiprofen | 2 |
125 | 4-aryl-nh-1,2,3-triazoles | 2 |
126 | 40gpa | 2 |
127 | 7-10mm | 2 |
128 | 8-plates | 2 |
129 | 850mpa | 2 |
130 | 8881 | 2 |
131 | 9-ing-41 | 2 |
132 | aceruloplasminemia | 2 |
133 | acubands | 2 |
134 | adamts12 | 2 |
135 | agtrpa1 | 2 |
136 | akirins | 2 |
137 | aliskerin | 2 |
138 | ambulations | 2 |
139 | anisakids | 2 |
140 | ashworthiosis | 2 |
141 | asms | 2 |
142 | back-pressure | 2 |
143 | barometeosensivity | 2 |
144 | bartonellosis | 2 |
145 | bebedouro | 2 |
146 | bianqueyun | 2 |
147 | blinding.there | 2 |
148 | cannabimimetics | 2 |
149 | carboxy-hmp | 2 |
150 | catft4 | 2 |
151 | cd11cdcs | 2 |
152 | ceftriaxone-vancomycin | 2 |
153 | cis-1,3-butadiene | 2 |
154 | cnv1014802 | 2 |
155 | consternation | 2 |
156 | ct-reconstructions | 2 |
157 | cv-prevention | 2 |
158 | dbhs | 2 |
159 | de-novo-utis | 2 |
160 | deinstitutionalisation | 2 |
161 | dl-las | 2 |
162 | dys14/gapdh | 2 |
163 | fcds | 2 |
164 | fillerina® | 2 |
165 | fluoxetine/norfluoxetine | 2 |
166 | gh14-3-3l | 2 |
167 | glutamate/cr | 2 |
168 | glutaminases | 2 |
169 | gralise® | 2 |
170 | gαq/11 | 2 |
171 | has-bled/chads2/cha2ds2-vasc | 2 |
172 | helleborus-implants | 2 |
173 | herbs/plants | 2 |
174 | herpetology | 2 |
175 | hsfa1a/hsfa1b | 2 |
176 | ichthyofauna | 2 |
177 | imidazothioxanthones | 2 |
178 | innuendo | 2 |
179 | insurgency | 2 |
180 | inter-region | 2 |
181 | interferon-d | 2 |
182 | isu303 | 2 |
183 | l-α-lysine | 2 |
184 | lb80331/lb80317 | 2 |
185 | lbpt | 2 |
186 | lc3b-ii/i | 2 |
187 | leucotrienes | 2 |
188 | lmcrc | 2 |
189 | m-components | 2 |
190 | macrovasculopathy | 2 |
191 | maxsar10g | 2 |
192 | mexico-tenochtitlan | 2 |
193 | mmscs | 2 |
194 | morbi/mortality | 2 |
195 | n=1186 | 2 |
196 | neuroimmunology | 2 |
197 | non-directiveness | 2 |
198 | ommoord | 2 |
199 | osnabrueck | 2 |
200 | outcomes.this | 2 |
201 | p.jirovecii | 2 |
202 | p53-ntd | 2 |
203 | paramphistomosis | 2 |
204 | periodontists | 2 |
205 | pf-04605412 | 2 |
206 | pgrn+cells | 2 |
207 | photosynthates | 2 |
208 | polymorphonucleates | 2 |
209 | pre-beta0 | 2 |
210 | pregrade | 2 |
211 | pseudosymmetry | 2 |
212 | psychotropes | 2 |
213 | rab5b | 2 |
214 | registration/randomization | 2 |
215 | reosorbilact | 2 |
216 | riohacha | 2 |
217 | rs10811661 | 2 |
218 | rs5995355 | 2 |
219 | sahar | 2 |
220 | sarfatti | 2 |
221 | self-aggregated | 2 |
222 | sr2ceo4 | 2 |
223 | sti/rtis | 2 |
224 | sulpirde | 2 |
225 | tab2 | 2 |
226 | tetra-hidro-cannabinoid | 2 |
227 | thermoelectricity | 2 |
228 | thermoenzymes | 2 |
229 | tnf-alpha-blockers | 2 |
230 | totopara | 2 |
231 | triglycerides/cholesterol | 2 |
232 | turku-loimaa | 2 |
233 | vaso-regulation | 2 |
234 | vegf-a/c/d | 2 |
235 | vim-38 | 2 |
236 | wireworms | 2 |
237 | wr-ai1 | 2 |
238 | ¹²³i-adam | 2 |
239 | α-thalassaemia | 2 |
240 | α-thalassaemias | 2 |
241 | π-systems | 2 |
242 | ≥1:32 | 2 |
243 | 'harmony | 1 |
244 | +1·4° | 1 |
245 | -0.9kg | 1 |
246 | -2.4sd | 1 |
247 | 0.0300-15.0μg/ml | 1 |
248 | 0.04-0.45μg/l | 1 |
249 | 0.13μg/l | 1 |
250 | 0.27°±1.75° | 1 |
251 | 0.46±0.02g/g | 1 |
252 | 0.4kg | 1 |
253 | 0.52μm | 1 |
254 | 0.5ma | 1 |
255 | 0.6μg/g | 1 |
256 | 0.7195 | 1 |
257 | 0.72-0.74 | 1 |
258 | 0.744+/-0.06 | 1 |
259 | 0.8nm | 1 |
260 | 0.94-2.38 | 1 |
261 | 0.9742 | 1 |
262 | 0.9°-1.4° | 1 |
263 | 1,2,4-triazole-3-thiones | 1 |
264 | 1,2-diarylethanols | 1 |
265 | 1,3-nitroamines | 1 |
266 | 1,4-diyn-3-ols | 1 |
267 | 1-hepten-3-one | 1 |
268 | 1-methoxy-indole-3-carbinole | 1 |
269 | 1.6μm | 1 |
270 | 1.71-1.99 | 1 |
271 | 1.83mb | 1 |
272 | 10-15/1000 | 1 |
273 | 10-250kda | 1 |
274 | 100-300kgy | 1 |
275 | 100μm×100μm | 1 |
276 | 11-ocs | 1 |
277 | 15-60l/min | 1 |
278 | 17.4° | 1 |
279 | 18-hydroxyeicosapentaenoate | 1 |
280 | 18.3mg/dl | 1 |
281 | 18.4μm | 1 |
282 | 182°-186° | 1 |
283 | 18bp | 1 |
284 | 19-phenyl-dmag | 1 |
285 | 1917-1926 | 1 |
286 | 2'chlordesmethyldiazepam | 1 |
287 | 2,3-dichloropyrazine | 1 |
288 | 2,4,6-triazido-3-chloro-5-fluoropyridine | 1 |
289 | 2-2.5:1 | 1 |
290 | 2-acyl-1-hydroxy-2,3,1-diazaborines | 1 |
291 | 2-alkylazaarenes | 1 |
292 | 2-aminophenoxazin-3-ones | 1 |
293 | 2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamides | 1 |
294 | 2-substituted-3-sulfonylaminopyridine | 1 |
295 | 2.01-3.60 | 1 |
296 | 2.54cm/decade | 1 |
297 | 2.68cm/s | 1 |
298 | 21-22-mers | 1 |
299 | 22±2ºc | 1 |
300 | 25.7° | 1 |
301 | 29.3±5.7 | 1 |
302 | 3,6-dt | 1 |
303 | 3-aminopyrrolidine | 1 |
304 | 3-azidopiperidines | 1 |
305 | 3-ethoxycarbonyl-1-aza-9-oxafluorenes | 1 |
306 | 3-hydroxy-2,3-dihydroisoquinoline-1,4-diones | 1 |
307 | 3-hydroxy-3-trifluoromethylpyrazoles | 1 |
308 | 3-indolyl-3-aminooxindoles | 1 |
309 | 3-minopropyltriethoxysilane | 1 |
310 | 3-spiro-1,2-dihydropyrrolooxazine-5,7-dione-oxindole | 1 |
311 | 3.31-fold | 1 |
312 | 3.8-4.2 | 1 |
313 | 3/1,000/year | 1 |
314 | 31,626 | 1 |
315 | 31.4±14.5 | 1 |
316 | 325.8+14.5 | 1 |
317 | 37.1±9.0 | 1 |
318 | 37.6±7.9 | 1 |
319 | 4,4'-dihydroxy-2'6'-dimethoxydihydrochalcone | 1 |
320 | 4,418 | 1 |
321 | 4-aminoantipyrines | 1 |
322 | 4-ene | 1 |
323 | 4-hydroxycarbazol | 1 |
324 | 4.935 | 1 |
325 | 40-50l/min | 1 |
326 | 40mug/ml | 1 |
327 | 41.9±7.0 | 1 |
328 | 43.7±7.1 | 1 |
329 | 44.05ev | 1 |
330 | 440nm | 1 |
331 | 450-700nm | 1 |
332 | 45ca | 1 |
333 | 5-20k/min | 1 |
334 | 5-hydroxypropafenone | 1 |
335 | 5.1-1.0 | 1 |
336 | 5.45cm/s | 1 |
337 | 5.7+/-1.1 | 1 |
338 | 50°c/min | 1 |
339 | 51,523 | 1 |
340 | 51,965 | 1 |
341 | 5100a4 | 1 |
342 | 5ht3-receptors | 1 |
343 | 6+/-0.95 | 1 |
344 | 6-7-fold | 1 |
345 | 6.4±2.5nm | 1 |
346 | 605,900 | 1 |
347 | 61emu/g | 1 |
348 | 634.1 | 1 |
349 | 65.82 | 1 |
350 | 7'-demethoxypurpuromycin | 1 |
351 | 7-substituted-3-methyl-quinoxalin-2-ones | 1 |
352 | 75-78gy | 1 |
353 | 8132euro | 1 |
354 | 90°/s | 1 |
355 | 95,816 | 1 |
356 | 99,961 | 1 |
357 | aba-8'-hydroxylase | 1 |
358 | abeta-plaques | 1 |
359 | ace/nep | 1 |
360 | ach-vasodilation | 1 |
361 | adapto | 1 |
362 | age/appearance | 1 |
363 | agrammatism | 1 |
364 | agratroban | 1 |
365 | ala/sod | 1 |
366 | alixetimia | 1 |
367 | alkalinephophatases | 1 |
368 | aloglipin | 1 |
369 | alpha-l-fucosidase | 1 |
370 | alterationsseen | 1 |
371 | am-treatments | 1 |
372 | amastigote/nests | 1 |
373 | amino-benzothiazole | 1 |
374 | aml/at | 1 |
375 | ammonemia | 1 |
376 | anti-hsp-60 | 1 |
377 | anti-il12/23 | 1 |
378 | anti-mdr | 1 |
379 | antinocecieption | 1 |
380 | appliance.no | 1 |
381 | arbs/aceis | 1 |
382 | artificiality | 1 |
383 | asd/ptsd | 1 |
384 | asialogangliosides | 1 |
385 | asn330 | 1 |
386 | atropselectively | 1 |
387 | atskip | 1 |
388 | atypicalities | 1 |
389 | autostereoscopy | 1 |
390 | azd3480-resulting | 1 |
391 | baby-bust | 1 |
392 | baruo3 | 1 |
393 | basic-skills | 1 |
394 | bavanat | 1 |
395 | behbahan | 1 |
396 | beida | 1 |
397 | benzopyrones | 1 |
398 | beta-1-receptors | 1 |
399 | beta-adrenoceptor-blockers | 1 |
400 | beta-aspartylglycine | 1 |
401 | beta-barrels | 1 |
402 | beta2-mimetics | 1 |
403 | bg-involvement | 1 |
404 | bilirubinaemia | 1 |
405 | biradicals | 1 |
406 | blavim-2 | 1 |
407 | bleeding-culminating | 1 |
408 | blepharismins | 1 |
409 | bojnord | 1 |
410 | bonavita | 1 |
411 | bps/pathways | 1 |
412 | bs/cholesterol | 1 |
413 | c9-c17 | 1 |
414 | ca-atp | 1 |
415 | cangzhou | 1 |
416 | carboplatinum/cisplatinum | 1 |
417 | carpospores | 1 |
418 | carão | 1 |
419 | caspase-3mrna | 1 |
420 | ccl19/21 | 1 |
421 | ccm-3·stripak | 1 |
422 | cerebroplegia | 1 |
423 | cervicocarcinoma | 1 |
424 | cetuximab/paclitaxel/carboplatin | 1 |
425 | cgg-triplets | 1 |
426 | che-inhibitors | 1 |
427 | chemoregimens | 1 |
428 | chest-findings | 1 |
429 | chlorophototrophs | 1 |
430 | cho/protein/fat | 1 |
431 | chokchokia | 1 |
432 | chorioangiopagus | 1 |
433 | chpla2-iie | 1 |
434 | ciiio | 1 |
435 | cis-cgas | 1 |
436 | cisplatin/doxorubicin | 1 |
437 | clairthromycin | 1 |
438 | clamidospores | 1 |
439 | clilostazol | 1 |
440 | cni/steroids | 1 |
441 | co-dependence | 1 |
442 | co-detections | 1 |
443 | coccoidea | 1 |
444 | colpo-cervicitis | 1 |
445 | combustion-derived-nanoparticles | 1 |
446 | comfort/stability | 1 |
447 | concordance/discordance | 1 |
448 | constantinople | 1 |
449 | conversion/reversion | 1 |
450 | crhsfs | 1 |
451 | cross-combination | 1 |
452 | cyp2d2 | 1 |
453 | cytostome | 1 |
454 | d124a | 1 |
455 | d19s884 | 1 |
456 | damp-beat | 1 |
457 | de-acclimation | 1 |
458 | deat | 1 |
459 | death/mi/ur | 1 |
460 | defct | 1 |
461 | deletions/mutations | 1 |
462 | deoxidation | 1 |
463 | dependence-independence | 1 |
464 | depression-detection | 1 |
465 | depression-diagnosis | 1 |
466 | dichromates | 1 |
467 | dispirooxindolopyrrolidines | 1 |
468 | disruption-replenishment | 1 |
469 | distress/avoidance | 1 |
470 | dopaminomimetics | 1 |
471 | double-j-stents | 1 |
472 | dpb1*0501 | 1 |
473 | dyhydroergotamine | 1 |
474 | dypnoea | 1 |
475 | dysgeucia | 1 |
476 | dysport/eye | 1 |
477 | e-technologies | 1 |
478 | ebv/p24 | 1 |
479 | ecd1 | 1 |
480 | echo-exam | 1 |
481 | ecotechnology | 1 |
482 | ed-mild | 1 |
483 | edwardsiellosis | 1 |
484 | ees/bms | 1 |
485 | eigenchannels | 1 |
486 | empires | 1 |
487 | engord | 1 |
488 | enos-signaling | 1 |
489 | eosinophillia | 1 |
490 | erk-1/-2 | 1 |
491 | erwadi | 1 |
492 | esterified-cholesterol | 1 |
493 | ethinl-estradiol | 1 |
494 | ev71-hsp90 | 1 |
495 | exooceanography | 1 |
496 | expertness | 1 |
497 | extracellulary | 1 |
498 | exu | 1 |
499 | f-18-fdg-pet | 1 |
500 | fe-s-p | 1 |
501 | fentaryl | 1 |
502 | fetes | 1 |
503 | fiborsarcoma | 1 |
504 | fiche | 1 |
505 | fistulaes | 1 |
506 | fit-2-play™ | 1 |
507 | fitc-bsa | 1 |
508 | flareups | 1 |
509 | flavonoid-glycosides | 1 |
510 | flavonoïds | 1 |
511 | fluoroapetite | 1 |
512 | foragers-farmers | 1 |
513 | franciselliosis | 1 |
514 | friary | 1 |
515 | fx06 | 1 |
516 | f₀-value | 1 |
517 | g7minigp4 | 1 |
518 | gaba-b-rs | 1 |
519 | galecti-3c | 1 |
520 | gamma-mpts | 1 |
521 | gastricatony | 1 |
522 | gata-3mrna | 1 |
523 | gelectin-3 | 1 |
524 | ghcesa | 1 |
525 | gilgit | 1 |
526 | ginsensides | 1 |
527 | glossoptosis | 1 |
528 | glutathione-conjugation | 1 |
529 | glycals | 1 |
530 | glycated-lz | 1 |
531 | glycerate-1,3-bisphosphate | 1 |
532 | gmgamyb1 | 1 |
533 | gmhsp22 | 1 |
534 | goma | 1 |
535 | gorgoniaceae | 1 |
536 | gs-3 | 1 |
537 | gsk-3/zw3 | 1 |
538 | guayana | 1 |
539 | guediawaye | 1 |
540 | guelma | 1 |
541 | h1h | 1 |
542 | he-terogeneity | 1 |
543 | hematocrit/hemoglobin | 1 |
544 | hemocolitis | 1 |
545 | hemophagocytes | 1 |
546 | hemorrhage-and | 1 |
547 | hepotoma | 1 |
548 | her3-imaging | 1 |
549 | hif-α/vegf-a | 1 |
550 | higfbp-3 | 1 |
551 | hil-10 | 1 |
552 | hsf1/hsp | 1 |
553 | hsp/hsc70s | 1 |
554 | hydrocele/spermatocele | 1 |
555 | hydrodynamism | 1 |
556 | hypergraph | 1 |
557 | iatrogenicity | 1 |
558 | ige/il-4 | 1 |
559 | igg-anti-lps | 1 |
560 | il-17/il-17a | 1 |
561 | il-17/il-23 | 1 |
562 | ilbl | 1 |
563 | immuno-nutrition | 1 |
564 | immunodysfunction | 1 |
565 | impedancemetry | 1 |
566 | impella-2.5-application | 1 |
567 | impella-2.5-support | 1 |
568 | importance/interest | 1 |
569 | inflammatory-mediators | 1 |
570 | inflximab | 1 |
571 | information/awareness | 1 |
572 | injectisomes | 1 |
573 | inos/no | 1 |
574 | interculturality | 1 |
575 | interferon-tau | 1 |
576 | itineracy | 1 |
577 | itks | 1 |
578 | k-factors | 1 |
579 | kalasugay | 1 |
580 | kasianowicz | 1 |
581 | knee-bends | 1 |
582 | kolff | 1 |
583 | korean-ness | 1 |
584 | kosko | 1 |
585 | koupela | 1 |
586 | kuppaimeni | 1 |
587 | l-opsin | 1 |
588 | lactate/hca1 | 1 |
589 | lactose-adducts | 1 |
590 | lampalizumab | 1 |
591 | ld4 | 1 |
592 | ldl-cholesterol-values | 1 |
593 | lerkanidipine | 1 |
594 | life-cultivation | 1 |
595 | lipds | 1 |
596 | lithium+valproate | 1 |
597 | longhouses | 1 |
598 | lovastotin | 1 |
599 | lubumbashi | 1 |
600 | luciferase-refolding | 1 |
601 | lumiflavin | 1 |
602 | lung-inflammation | 1 |
603 | lungworms | 1 |
604 | lys-lys | 1 |
605 | m-cholinoreactivity | 1 |
606 | macroinfarction | 1 |
607 | maguks | 1 |
608 | mastigophora | 1 |
609 | meaning-construction | 1 |
610 | mechano-responsiveness | 1 |
611 | mediterraneanism | 1 |
612 | melamine-contamination | 1 |
613 | melanospheres | 1 |
614 | met90 | 1 |
615 | metal/cofactor | 1 |
616 | metal/contaminant | 1 |
617 | metformin-sibutramine | 1 |
618 | mfsn | 1 |
619 | mimividae | 1 |
620 | mitrapide | 1 |
621 | mmp-2-levels | 1 |
622 | mmpss | 1 |
623 | molybdenosis | 1 |
624 | mr-ht | 1 |
625 | multicyte™ | 1 |
626 | munc18-1/2 | 1 |
627 | mutations/haplotypes | 1 |
628 | mva-5t4/placebo | 1 |
629 | myl9 | 1 |
630 | mylagaulids | 1 |
631 | n-alkyl-2-aryl-indole-3-carbaldehyde | 1 |
632 | na-h275y | 1 |
633 | nanoelements | 1 |
634 | nbtft4 | 1 |
635 | nec/septicemia | 1 |
636 | nectin-1/-2 | 1 |
637 | neptunium | 1 |
638 | neuro-deficit | 1 |
639 | neuromaturity | 1 |
640 | neurotrophines | 1 |
641 | nf-κb-activity | 1 |
642 | nk₃r | 1 |
643 | nmmhc-iia | 1 |
644 | non-iw | 1 |
645 | nonapeptides | 1 |
646 | nonconsent | 1 |
647 | norrbotten | 1 |
648 | oat-supplement | 1 |
649 | obesity-indices | 1 |
650 | oh-radicals | 1 |
651 | oilworkers | 1 |
652 | one-eye-sleep | 1 |
653 | opr-150 | 1 |
654 | org10172 | 1 |
655 | otodectosis | 1 |
656 | oxaliplatin/5-fluorouracil/leucovorin | 1 |
657 | oxaliplatin/fluorouracil/leucovorin | 1 |
658 | p257 | 1 |
659 | p42s | 1 |
660 | p89l | 1 |
661 | paaf1 | 1 |
662 | pain/time | 1 |
663 | pan-vasculitis | 1 |
664 | paralytics | 1 |
665 | parkisonism | 1 |
666 | pas-c | 1 |
667 | past-stroke | 1 |
668 | patho-phenotypes | 1 |
669 | patriarchy | 1 |
670 | pc-acro | 1 |
671 | pcutis | 1 |
672 | pdhp | 1 |
673 | pharmachotherapy | 1 |
674 | pharmacodiagnostics | 1 |
675 | phenyhydrazone-derivatives | 1 |
676 | pheromonogenesis | 1 |
677 | phospho-ikb-α | 1 |
678 | phosphono-γ-butyrolactones | 1 |
679 | phosphorylated-camkii-α | 1 |
680 | phosphotyrosine-stat6 | 1 |
681 | photoelectrons | 1 |
682 | physiologists-notably | 1 |
683 | phyto-anti-oestrogens | 1 |
684 | phytonematodes | 1 |
685 | phytosynergy | 1 |
686 | phytotherapics | 1 |
687 | pill-placebos | 1 |
688 | piogliazone | 1 |
689 | pipercillin/tazobactam | 1 |
690 | plm-to-lymphadenitis | 1 |
691 | plows | 1 |
692 | pohnpei | 1 |
693 | polypartnerism | 1 |
694 | polyunsaturation | 1 |
695 | poroids | 1 |
696 | positive-reaction | 1 |
697 | post-positivism | 1 |
698 | pound323.85 | 1 |
699 | ppargamma-activation | 1 |
700 | pph-33 | 1 |
701 | prescription/drug | 1 |
702 | probiotica | 1 |
703 | progressivism | 1 |
704 | protein/igg | 1 |
705 | pruritogenesis | 1 |
706 | psa-use | 1 |
707 | pseudoerosions | 1 |
708 | pseudohyperkalemia | 1 |
709 | pseudopterygium | 1 |
710 | pterins | 1 |
711 | pyrethroid-resistance | 1 |
712 | q226i | 1 |
713 | qi-blood-yin-yang | 1 |
714 | questions/probes | 1 |
715 | r-btps | 1 |
716 | r.mori | 1 |
717 | r354a/s358a | 1 |
718 | radioguidance | 1 |
719 | raltitrexed-oxaliplatin | 1 |
720 | re-flare | 1 |
721 | redox-reactions | 1 |
722 | residronate | 1 |
723 | rgc-res | 1 |
724 | rhmbp-2 | 1 |
725 | rhuil-1ra | 1 |
726 | ribaviron | 1 |
727 | rilotumumab±epirubicin/cisplatin/capecitabine | 1 |
728 | ringkøbing | 1 |
729 | rivierduinen | 1 |
730 | ro4905417 | 1 |
731 | roussaint | 1 |
732 | rs2705897 | 1 |
733 | rs2724635 | 1 |
734 | rs3118570 | 1 |
735 | rs500766 | 1 |
736 | rvx000222 | 1 |
737 | rxralpha/gamma | 1 |
738 | s-waves | 1 |
739 | s1p2-3 | 1 |
740 | scabicides | 1 |
741 | sdf-1αsignaling | 1 |
742 | secalins | 1 |
743 | seleno-proteins | 1 |
744 | self-infection | 1 |
745 | semenogelin | 1 |
746 | separatrices | 1 |
747 | ser215 | 1 |
748 | serca2a/phospholamban | 1 |
749 | serine105 | 1 |
750 | sessions/patient | 1 |
751 | shamasan | 1 |
752 | sholapur | 1 |
753 | si-screws | 1 |
754 | silver-resistance | 1 |
755 | smart-soup | 1 |
756 | soroosh | 1 |
757 | spd503 | 1 |
758 | species-differences | 1 |
759 | spiro-phosphonylpyrazoline-oxindoles | 1 |
760 | sreemangal | 1 |
761 | srif-receptors | 1 |
762 | stat92e | 1 |
763 | stent-therapy | 1 |
764 | stentgrafts | 1 |
765 | sterotypies | 1 |
766 | streptocephalidae | 1 |
767 | stw5/iberogast | 1 |
768 | submarining | 1 |
769 | sulfamates | 1 |
770 | sulfhydryl-compounds | 1 |
771 | summands | 1 |
772 | superionicity | 1 |
773 | sv2 | 1 |
774 | symphills | 1 |
775 | synecdoche | 1 |
776 | syphilis-especially | 1 |
777 | szkjy | 1 |
778 | t-3-bpnps | 1 |
779 | t-regulators | 1 |
780 | tacticity | 1 |
781 | tasase | 1 |
782 | tcam/spirituality | 1 |
783 | tcdg | 1 |
784 | tehuantepec | 1 |
785 | tel1 | 1 |
786 | ter152arg | 1 |
787 | th-immunoreactivity | 1 |
788 | th1-cytokines | 1 |
789 | thermo-adaptability | 1 |
790 | thiazolopyridine-2-carbonitriles | 1 |
791 | thienopyrindines | 1 |
792 | thr567 | 1 |
793 | thread-moxa | 1 |
794 | tim-3/tim-1 | 1 |
795 | tnf-inhibitors | 1 |
796 | tokombéré | 1 |
797 | toxic-elements | 1 |
798 | toxoplamosis | 1 |
799 | treatment-to-delivery | 1 |
800 | triarylpyrrolines | 1 |
801 | troglostrongylosis | 1 |
802 | tumkur | 1 |
803 | unimportance | 1 |
804 | unthealth | 1 |
805 | upmilk | 1 |
806 | up—finally | 1 |
807 | urates | 1 |
808 | ureases | 1 |
809 | users-relatives | 1 |
810 | uti/symptoms | 1 |
811 | uv-level | 1 |
812 | vaccine-hpiv3 | 1 |
813 | vaccinetherapy | 1 |
814 | val32met | 1 |
815 | valp | 1 |
816 | variability/uncertainty | 1 |
817 | vce-use | 1 |
818 | veillard | 1 |
819 | venlocity | 1 |
820 | videodermatoscopy | 1 |
821 | vitespan | 1 |
822 | vldl-synthesis | 1 |
823 | volociximab | 1 |
824 | warfarization | 1 |
825 | wood/food | 1 |
826 | worker-motivation | 1 |
827 | wu-variability | 1 |
828 | yaba-users | 1 |
829 | zf-3-ost-4 | 1 |
830 | zinc-neutralization | 1 |
831 | znbr2 | 1 |
832 | ~650,000 | 1 |
833 | £14,618 | 1 |
834 | £3488.3 | 1 |
835 | £388,719 | 1 |
836 | α9-nachrs | 1 |
837 | αtnf-blockers | 1 |
838 | β-interferon | 1 |
839 | β-lysine | 1 |
840 | β2agonists | 1 |
841 | γ-12:1 | 1 |
842 | ε-nh2 | 1 |
843 | π-character | 1 |
844 | €11,438/qaly | 1 |
845 | €3434/qaly | 1 |
846 | €581 | 1 |
847 | €59.08 | 1 |
848 | €635 | 1 |
849 | ≈eightfold | 1 |
850 | ≤1.20 | 1 |
1 | 'harmony | 1 |
2 | 'trends | 2 |
3 | +1·4° | 1 |
4 | -0.9kg | 1 |
5 | -2.4sd | 1 |
6 | 0.0300-15.0μg/ml | 1 |
7 | 0.04-0.45μg/l | 1 |
8 | 0.13μg/l | 1 |
9 | 0.27°±1.75° | 1 |
10 | 0.46±0.02g/g | 1 |
11 | 0.4kg | 1 |
12 | 0.52μm | 1 |
13 | 0.5ma | 1 |
14 | 0.6μg/g | 1 |
15 | 0.7195 | 1 |
16 | 0.72-0.74 | 1 |
17 | 0.744+/-0.06 | 1 |
18 | 0.8nm | 1 |
19 | 0.94-2.38 | 1 |
20 | 0.9742 | 1 |
21 | 0.9°-1.4° | 1 |
22 | 1,2,4-triazole-3-thiones | 1 |
23 | 1,2-diarylethanols | 1 |
24 | 1,3-nitroamines | 1 |
25 | 1,4-diyn-3-ols | 1 |
26 | 1-hepten-3-one | 1 |
27 | 1-methoxy-indole-3-carbinole | 1 |
28 | 1.6μm | 1 |
29 | 1.71-1.99 | 1 |
30 | 1.83mb | 1 |
31 | 10-15/1000 | 1 |
32 | 10-250kda | 1 |
33 | 10/100,000 | 2 |
34 | 100-300kgy | 1 |
35 | 100μm×100μm | 1 |
36 | 11-ocs | 1 |
37 | 113min-dtpa | 5 |
38 | 1368insc | 2 |
39 | 15-60l/min | 1 |
40 | 15-f2alpha-isoprostane | 3 |
41 | 169yb-dtpa | 9 |
42 | 17.4° | 1 |
43 | 18-hydroxyeicosapentaenoate | 1 |
44 | 18.3mg/dl | 1 |
45 | 18.4μm | 1 |
46 | 182°-186° | 1 |
47 | 18bp | 1 |
48 | 18f-fdg-pet | 2 |
49 | 19,731 | 3 |
50 | 19-phenyl-dmag | 1 |
51 | 1917-1926 | 1 |
52 | 2'chlordesmethyldiazepam | 1 |
53 | 2,3-dichloropyrazine | 1 |
54 | 2,4,6-triazido-3-chloro-5-fluoropyridine | 1 |
55 | 2-2.5:1 | 1 |
56 | 2-acyl-1-hydroxy-2,3,1-diazaborines | 1 |
57 | 2-alkylazaarenes | 1 |
58 | 2-aminophenoxazin-3-ones | 1 |
59 | 2-bromobenzaldehydes | 2 |
60 | 2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamides | 1 |
61 | 2-substituted-3-sulfonylaminopyridine | 1 |
62 | 2.01-3.60 | 1 |
63 | 2.54cm/decade | 1 |
64 | 2.68cm/s | 1 |
65 | 2.8:1 | 2 |
66 | 200-400nm | 2 |
67 | 21-22-mers | 1 |
68 | 22±2ºc | 1 |
69 | 25.7° | 1 |
70 | 29.3±5.7 | 1 |
71 | 3,103 | 2 |
72 | 3,5-dien-1-ynes | 2 |
73 | 3,6-dt | 1 |
74 | 3-aminopyrrolidine | 1 |
75 | 3-azidopiperidines | 1 |
76 | 3-coumaranones | 2 |
77 | 3-ethoxycarbonyl-1-aza-9-oxafluorenes | 1 |
78 | 3-ethoxymethyl-1,4-dihydroquinolin-4-one | 2 |
79 | 3-hydroxy-2,3-dihydroisoquinoline-1,4-diones | 1 |
80 | 3-hydroxy-3-trifluoromethylpyrazoles | 1 |
81 | 3-indolyl-3-aminooxindoles | 1 |
82 | 3-minopropyltriethoxysilane | 1 |
83 | 3-spiro-1,2-dihydropyrrolooxazine-5,7-dione-oxindole | 1 |
84 | 3.31-fold | 1 |
85 | 3.8-4.2 | 1 |
86 | 3/1,000/year | 1 |
87 | 31,626 | 1 |
88 | 31.4±14.5 | 1 |
89 | 325.8+14.5 | 1 |
90 | 37.1±9.0 | 1 |
91 | 37.6±7.9 | 1 |
92 | 4'-hydroxyflurbiprofen | 2 |
93 | 4,4'-dihydroxy-2'6'-dimethoxydihydrochalcone | 1 |
94 | 4,418 | 1 |
95 | 4-aminoantipyrines | 1 |
96 | 4-aryl-nh-1,2,3-triazoles | 2 |
97 | 4-ene | 1 |
98 | 4-hydroxycarbazol | 1 |
99 | 4.935 | 1 |
100 | 40-50l/min | 1 |
101 | 40gpa | 2 |
102 | 40mug/ml | 1 |
103 | 41.9±7.0 | 1 |
104 | 43.7±7.1 | 1 |
105 | 44.05ev | 1 |
106 | 440nm | 1 |
107 | 450-700nm | 1 |
108 | 45ca | 1 |
109 | 5-20k/min | 1 |
110 | 5-hydroxypropafenone | 1 |
111 | 5.1-1.0 | 1 |
112 | 5.45cm/s | 1 |
113 | 5.7+/-1.1 | 1 |
114 | 50°c/min | 1 |
115 | 51,523 | 1 |
116 | 51,965 | 1 |
117 | 5100a4 | 1 |
118 | 5ht3-receptors | 1 |
119 | 6+/-0.95 | 1 |
120 | 6-7-fold | 1 |
121 | 6.4±2.5nm | 1 |
122 | 605,900 | 1 |
123 | 61emu/g | 1 |
124 | 634.1 | 1 |
125 | 65.82 | 1 |
126 | 7'-demethoxypurpuromycin | 1 |
127 | 7-10mm | 2 |
128 | 7-substituted-3-methyl-quinoxalin-2-ones | 1 |
129 | 75-78gy | 1 |
130 | 8-plates | 2 |
131 | 8132euro | 1 |
132 | 850mpa | 2 |
133 | 8881 | 2 |
134 | 9-ing-41 | 2 |
135 | 90°/s | 1 |
136 | 95,816 | 1 |
137 | 99,961 | 1 |
138 | aba-8'-hydroxylase | 1 |
139 | abeta-plaques | 1 |
140 | ace/nep | 1 |
141 | aceruloplasminemia | 2 |
142 | ach-vasodilation | 1 |
143 | acra4 | 3 |
144 | acubands | 2 |
145 | ad5.sstr/tk.rgd | 5 |
146 | adamts12 | 2 |
147 | adapto | 1 |
148 | advantame | 3 |
149 | age/appearance | 1 |
150 | agrammatism | 1 |
151 | agratroban | 1 |
152 | agtrpa1 | 2 |
153 | akirins | 2 |
154 | ala/sod | 1 |
155 | aliskerin | 2 |
156 | alixetimia | 1 |
157 | alkalinephophatases | 1 |
158 | all-trans-beta-carotene | 8 |
159 | allylsilanes | 3 |
160 | aloglipin | 1 |
161 | alpha-l-fucosidase | 1 |
162 | alpha-lithics | 4 |
163 | alterationsseen | 1 |
164 | am-treatments | 1 |
165 | amastigote/nests | 1 |
166 | ambulations | 2 |
167 | amino-benzothiazole | 1 |
168 | aml/at | 1 |
169 | ammonemia | 1 |
170 | amphenicols | 8 |
171 | anisakids | 2 |
172 | anti-hsp-60 | 1 |
173 | anti-il12/23 | 1 |
174 | anti-mdr | 1 |
175 | antinocecieption | 1 |
176 | appliance.no | 1 |
177 | arbovirus | 6 |
178 | arbs/aceis | 1 |
179 | arc-welding | 3 |
180 | artificiality | 1 |
181 | asd/ptsd | 1 |
182 | ashworthiosis | 2 |
183 | asialogangliosides | 1 |
184 | asms | 2 |
185 | asn330 | 1 |
186 | atropselectively | 1 |
187 | atskip | 1 |
188 | atypicalities | 1 |
189 | autostereoscopy | 1 |
190 | azd3480-resulting | 1 |
191 | baby-bust | 1 |
192 | back-pressure | 2 |
193 | barometeosensivity | 2 |
194 | bartonellosis | 2 |
195 | baruo3 | 1 |
196 | basic-skills | 1 |
197 | bavanat | 1 |
198 | bebedouro | 2 |
199 | behbahan | 1 |
200 | beida | 1 |
201 | benzopyrones | 1 |
202 | bereztem | 3 |
203 | beta-1-receptors | 1 |
204 | beta-adrenoceptor-blockers | 1 |
205 | beta-aspartylglycine | 1 |
206 | beta-barrels | 1 |
207 | beta2-mimetics | 1 |
208 | bettolepsy | 4 |
209 | bg-involvement | 1 |
210 | bianqueyun | 2 |
211 | bilirubinaemia | 1 |
212 | biradicals | 1 |
213 | blavim-2 | 1 |
214 | bleeding-culminating | 1 |
215 | blepharismins | 1 |
216 | blinding.there | 2 |
217 | bojnord | 1 |
218 | bonavita | 1 |
219 | bps/pathways | 1 |
220 | bs/cholesterol | 1 |
221 | bucinnazine | 3 |
222 | c-425 | 9 |
223 | c2gnt-m | 4 |
224 | c9-c17 | 1 |
225 | ca-atp | 1 |
226 | ca130 | 8 |
227 | cangzhou | 1 |
228 | cannabimimetics | 2 |
229 | capsulodesis | 3 |
230 | carboplatinum/cisplatinum | 1 |
231 | carboxy-hmp | 2 |
232 | carpospores | 1 |
233 | carão | 1 |
234 | caspase-3mrna | 1 |
235 | catft4 | 2 |
236 | ccl19/21 | 1 |
237 | ccm-3·stripak | 1 |
238 | cd11cdcs | 2 |
239 | ceftriaxone-vancomycin | 2 |
240 | cerebroplegia | 1 |
241 | cerl2 | 5 |
242 | cervicocarcinoma | 1 |
243 | cetuximab/paclitaxel/carboplatin | 1 |
244 | cgg-triplets | 1 |
245 | che-inhibitors | 1 |
246 | chemoregimens | 1 |
247 | chest-findings | 1 |
248 | chimaphilin | 5 |
249 | chlorophototrophs | 1 |
250 | cho/protein/fat | 1 |
251 | chokchokia | 1 |
252 | chorioangiopagus | 1 |
253 | chpla2-iie | 1 |
254 | ciiio | 1 |
255 | cis-1,3-butadiene | 2 |
256 | cis-cgas | 1 |
257 | cisplatin/doxorubicin | 1 |
258 | cladocroce | 3 |
259 | clairthromycin | 1 |
260 | clamidospores | 1 |
261 | clilostazol | 1 |
262 | cni/steroids | 1 |
263 | cnv1014802 | 2 |
264 | co-dependence | 1 |
265 | co-detections | 1 |
266 | coccoidea | 1 |
267 | colpo-cervicitis | 1 |
268 | combustion-derived-nanoparticles | 1 |
269 | comfort/stability | 1 |
270 | concordance/discordance | 1 |
271 | constantinople | 1 |
272 | consternation | 2 |
273 | control/self-efficacy | 4 |
274 | conversion/reversion | 1 |
275 | coping-together | 8 |
276 | crf2rs | 3 |
277 | crhsfs | 1 |
278 | crmpk3 | 6 |
279 | cross-combination | 1 |
280 | cs-1170 | 6 |
281 | ct-reconstructions | 2 |
282 | curassow | 4 |
283 | cv-prevention | 2 |
284 | cyp2d2 | 1 |
285 | cyrilovite | 7 |
286 | cytostome | 1 |
287 | d124a | 1 |
288 | d19s884 | 1 |
289 | damp-beat | 1 |
290 | dbhs | 2 |
291 | de-acclimation | 1 |
292 | de-novo-utis | 2 |
293 | deat | 1 |
294 | death/mi/ur | 1 |
295 | defct | 1 |
296 | deinstitutionalisation | 2 |
297 | deletions/mutations | 1 |
298 | deoxidation | 1 |
299 | dependence-independence | 1 |
300 | depression-detection | 1 |
301 | depression-diagnosis | 1 |
302 | deseases | 3 |
303 | dichromates | 1 |
304 | dip-slides | 4 |
305 | dispirooxindolopyrrolidines | 1 |
306 | disruption-replenishment | 1 |
307 | distress/avoidance | 1 |
308 | dl-las | 2 |
309 | dopaminomimetics | 1 |
310 | double-j-stents | 1 |
311 | dpb1*0501 | 1 |
312 | drainages | 24 |
313 | dyhydroergotamine | 1 |
314 | dypnoea | 1 |
315 | dys14/gapdh | 2 |
316 | dysgeucia | 1 |
317 | dysport/eye | 1 |
318 | e-technologies | 1 |
319 | ebv/p24 | 1 |
320 | ecd1 | 1 |
321 | echo-exam | 1 |
322 | ecotechnology | 1 |
323 | ed-mild | 1 |
324 | edwardsiellosis | 1 |
325 | ees/bms | 1 |
326 | eigenchannels | 1 |
327 | empires | 1 |
328 | endoanchors | 7 |
329 | engord | 1 |
330 | enos-signaling | 1 |
331 | eosinophillia | 1 |
332 | erk-1/-2 | 1 |
333 | erwadi | 1 |
334 | esterified-cholesterol | 1 |
335 | ethinl-estradiol | 1 |
336 | ev71-hsp90 | 1 |
337 | evp-6124 | 5 |
338 | exo-β-1,3-galactanase | 3 |
339 | exooceanography | 1 |
340 | expertness | 1 |
341 | extracellulary | 1 |
342 | exu | 1 |
343 | eyas | 3 |
344 | f-18-fdg-pet | 1 |
345 | fcds | 2 |
346 | fdls | 6 |
347 | fe-s-p | 1 |
348 | fentaryl | 1 |
349 | fetes | 1 |
350 | fiborsarcoma | 1 |
351 | fiche | 1 |
352 | fidelities | 4 |
353 | fillerina® | 2 |
354 | fistulaes | 1 |
355 | fit-2-play™ | 1 |
356 | fitc-bsa | 1 |
357 | flareups | 1 |
358 | flavonoid-glycosides | 1 |
359 | flavonoïds | 1 |
360 | fluoroapetite | 1 |
361 | fluorospectrophotometry | 3 |
362 | fluoxetine/norfluoxetine | 2 |
363 | foragers-farmers | 1 |
364 | franciselliosis | 1 |
365 | fraxetin | 8 |
366 | friary | 1 |
367 | fx06 | 1 |
368 | f₀-value | 1 |
369 | g7minigp4 | 1 |
370 | gaba-b-rs | 1 |
371 | gal-galnac | 8 |
372 | galecti-3c | 1 |
373 | gamma-mpts | 1 |
374 | gastricatony | 1 |
375 | gastrodigenin | 7 |
376 | gata-3mrna | 1 |
377 | gdu | 5 |
378 | gelclair® | 3 |
379 | gelectin-3 | 1 |
380 | gh14-3-3l | 2 |
381 | ghcesa | 1 |
382 | gilgit | 1 |
383 | ginsensides | 1 |
384 | glossoptosis | 1 |
385 | glutamate/cr | 2 |
386 | glutaminases | 2 |
387 | glutathione-conjugation | 1 |
388 | glycals | 1 |
389 | glycated-lz | 1 |
390 | glycerate-1,3-bisphosphate | 1 |
391 | gmgamyb1 | 1 |
392 | gmhsp22 | 1 |
393 | goma | 1 |
394 | gorgoniaceae | 1 |
395 | gralise® | 2 |
396 | gs-3 | 1 |
397 | gsk-3/zw3 | 1 |
398 | gsk315234 | 7 |
399 | guayana | 1 |
400 | guediawaye | 1 |
401 | guelma | 1 |
402 | gαq/11 | 2 |
403 | h1h | 1 |
404 | hampton | 4 |
405 | has-bled/chads2/cha2ds2-vasc | 2 |
406 | he-terogeneity | 1 |
407 | helleborus-implants | 2 |
408 | hematocrit/hemoglobin | 1 |
409 | hemocolitis | 1 |
410 | hemophagocytes | 1 |
411 | hemorrhage-and | 1 |
412 | hepotoma | 1 |
413 | her3-imaging | 1 |
414 | herbs/plants | 2 |
415 | herpetology | 2 |
416 | hif-α/vegf-a | 1 |
417 | higfbp-3 | 1 |
418 | hil-10 | 1 |
419 | homogamy | 5 |
420 | hsf1/hsp | 1 |
421 | hsfa1a/hsfa1b | 2 |
422 | hsp/hsc70s | 1 |
423 | hydrocele/spermatocele | 1 |
424 | hydrocoeles | 5 |
425 | hydrodynamism | 1 |
426 | hydroxylysine | 3 |
427 | hypergraph | 1 |
428 | hypolipidaemics | 4 |
429 | h₂co₃ | 5 |
430 | iatrogenesis | 9 |
431 | iatrogenicity | 1 |
432 | ichthyofauna | 2 |
433 | ige/il-4 | 1 |
434 | igg-anti-lps | 1 |
435 | il-17/il-17a | 1 |
436 | il-17/il-23 | 1 |
437 | ilbl | 1 |
438 | imidazothioxanthones | 2 |
439 | immuno-nutrition | 1 |
440 | immunodysfunction | 1 |
441 | impedancemetry | 1 |
442 | impella-2.5-application | 1 |
443 | impella-2.5-support | 1 |
444 | importance/interest | 1 |
445 | inflammatory-mediators | 1 |
446 | inflximab | 1 |
447 | information/awareness | 1 |
448 | injectisomes | 1 |
449 | innuendo | 2 |
450 | inos/no | 1 |
451 | insurgency | 2 |
452 | inter-est | 3 |
453 | inter-region | 2 |
454 | interculturality | 1 |
455 | interest | 8,035 |
456 | interferon-d | 2 |
457 | interferon-tau | 1 |
458 | isu303 | 2 |
459 | itineracy | 1 |
460 | itks | 1 |
461 | jna-ud-6 | 4 |
462 | k-factors | 1 |
463 | kalasugay | 1 |
464 | kasianowicz | 1 |
465 | knee-bends | 1 |
466 | kolff | 1 |
467 | korean-ness | 1 |
468 | kosko | 1 |
469 | koupela | 1 |
470 | kuppaimeni | 1 |
471 | l-opsin | 1 |
472 | l-quebrachitol | 4 |
473 | l-α-lysine | 2 |
474 | lactate/hca1 | 1 |
475 | lactose-adducts | 1 |
476 | laevo-ornidazole | 7 |
477 | lampalizumab | 1 |
478 | lb80331/lb80317 | 2 |
479 | lbpt | 2 |
480 | lc3b-ii/i | 2 |
481 | ld4 | 1 |
482 | ldl-cholesterol-values | 1 |
483 | leeway | 5 |
484 | lerkanidipine | 1 |
485 | leucotrienes | 2 |
486 | life-cultivation | 1 |
487 | lipds | 1 |
488 | lithium+valproate | 1 |
489 | lmcrc | 2 |
490 | longhouses | 1 |
491 | lonipc | 3 |
492 | lovastotin | 1 |
493 | lpmes | 3 |
494 | lubumbashi | 1 |
495 | luciferase-refolding | 1 |
496 | lumiflavin | 1 |
497 | lung-inflammation | 1 |
498 | lungworms | 1 |
499 | lvsd/hf | 6 |
500 | ly2886721 | 3 |
501 | lys-lys | 1 |
502 | m-cholinoreactivity | 1 |
503 | m-components | 2 |
504 | macroinfarction | 1 |
505 | macrovasculopathy | 2 |
506 | maguks | 1 |
507 | mastigophora | 1 |
508 | maxsar10g | 2 |
509 | meaning-construction | 1 |
510 | meaninglessness | 4 |
511 | mechano-responsiveness | 1 |
512 | mediterraneanism | 1 |
513 | megacalycosis | 3 |
514 | melamine-contamination | 1 |
515 | melanospheres | 1 |
516 | met90 | 1 |
517 | metacinnabar | 4 |
518 | metal/cofactor | 1 |
519 | metal/contaminant | 1 |
520 | metallicity | 4 |
521 | metallosis | 3 |
522 | metformin-sibutramine | 1 |
523 | methanofuran | 3 |
524 | mexico-tenochtitlan | 2 |
525 | mfsn | 1 |
526 | micro-colonies | 3 |
527 | micropores | 18 |
528 | mimividae | 1 |
529 | mitrapide | 1 |
530 | mmp-2-levels | 1 |
531 | mmpss | 1 |
532 | mmscs | 2 |
533 | molybdenosis | 1 |
534 | monothioarsenate | 4 |
535 | morbi/mortality | 2 |
536 | mr-ht | 1 |
537 | msp142 | 3 |
538 | multi-constituent | 3 |
539 | multicyte™ | 1 |
540 | munc18-1/2 | 1 |
541 | mutations/haplotypes | 1 |
542 | mva-5t4/placebo | 1 |
543 | myl9 | 1 |
544 | mylagaulids | 1 |
545 | n-alkyl-2-aryl-indole-3-carbaldehyde | 1 |
546 | n=1186 | 2 |
547 | na-h275y | 1 |
548 | nanoelements | 1 |
549 | nbtft4 | 1 |
550 | nec/septicemia | 1 |
551 | nectin-1/-2 | 1 |
552 | neptunium | 1 |
553 | neuro-deficit | 1 |
554 | neuroimmunology | 2 |
555 | neuromaturity | 1 |
556 | neurotrophines | 1 |
557 | nf-κb-activity | 1 |
558 | nifeviroc | 3 |
559 | nk₃r | 1 |
560 | nmmhc-iia | 1 |
561 | non-directiveness | 2 |
562 | non-iw | 1 |
563 | nonapeptides | 1 |
564 | nonconsent | 1 |
565 | nondetection | 5 |
566 | norrbotten | 1 |
567 | nxf3 | 8 |
568 | oat-supplement | 1 |
569 | obesity-indices | 1 |
570 | oh-radicals | 1 |
571 | oilworkers | 1 |
572 | oirsiw | 4 |
573 | ommoord | 2 |
574 | one-eye-sleep | 1 |
575 | opr-150 | 1 |
576 | org10172 | 1 |
577 | osnabrueck | 2 |
578 | otodectosis | 1 |
579 | outcomes.this | 2 |
580 | oxaliplatin/5-fluorouracil/leucovorin | 1 |
581 | oxaliplatin/fluorouracil/leucovorin | 1 |
582 | p.jirovecii | 2 |
583 | p257 | 1 |
584 | p42s | 1 |
585 | p53-ntd | 2 |
586 | p89l | 1 |
587 | paaf1 | 1 |
588 | pain/time | 1 |
589 | pan-vasculitis | 1 |
590 | paracalcitol | 5 |
591 | paralytics | 1 |
592 | paramphistomosis | 2 |
593 | parkisonism | 1 |
594 | pas-c | 1 |
595 | past-stroke | 1 |
596 | pat-sm6 | 4 |
597 | patho-phenotypes | 1 |
598 | patriarchy | 1 |
599 | pawr | 4 |
600 | pc-acro | 1 |
601 | pcutis | 1 |
602 | pdhp | 1 |
603 | periodontists | 2 |
604 | pf-04605412 | 2 |
605 | pgrn+cells | 2 |
606 | pharmachotherapy | 1 |
607 | pharmacodiagnostics | 1 |
608 | phenyhydrazone-derivatives | 1 |
609 | pheromonogenesis | 1 |
610 | phospho-ikb-α | 1 |
611 | phosphono-γ-butyrolactones | 1 |
612 | phosphorylated-camkii-α | 1 |
613 | phosphotyrosine-stat6 | 1 |
614 | photoelectrons | 1 |
615 | photosynthates | 2 |
616 | physiologists-notably | 1 |
617 | phyto-anti-oestrogens | 1 |
618 | phytonematodes | 1 |
619 | phytosterols/-stanols | 4 |
620 | phytosynergy | 1 |
621 | phytotherapics | 1 |
622 | pill-placebos | 1 |
623 | piogliazone | 1 |
624 | pipercillin/tazobactam | 1 |
625 | plant-parts | 5 |
626 | plm-to-lymphadenitis | 1 |
627 | plows | 1 |
628 | pohnpei | 1 |
629 | polymorphonucleates | 2 |
630 | polypartnerism | 1 |
631 | polyphenylene | 3 |
632 | polyunsaturation | 1 |
633 | poroids | 1 |
634 | positive-reaction | 1 |
635 | post-positivism | 1 |
636 | pound323.85 | 1 |
637 | ppargamma-activation | 1 |
638 | pph-33 | 1 |
639 | pre-beta0 | 2 |
640 | pregrade | 2 |
641 | prescription/drug | 1 |
642 | probiotica | 1 |
643 | probiotics/synbiotics | 4 |
644 | progressivism | 1 |
645 | protein/igg | 1 |
646 | pruritogenesis | 1 |
647 | psa-use | 1 |
648 | psb28 | 3 |
649 | pseudoerosions | 1 |
650 | pseudohyperkalemia | 1 |
651 | pseudopterygium | 1 |
652 | pseudosymmetry | 2 |
653 | psp/lvesv | 4 |
654 | psychotropes | 2 |
655 | pterins | 1 |
656 | pyraoxystrobin | 3 |
657 | pyrethroid-resistance | 1 |
658 | pyrrolizidines | 3 |
659 | q226i | 1 |
660 | qi-blood-yin-yang | 1 |
661 | questions/probes | 1 |
662 | r-btps | 1 |
663 | r.mori | 1 |
664 | r354a/s358a | 1 |
665 | rab5b | 2 |
666 | radioguidance | 1 |
667 | raltitrexed-oxaliplatin | 1 |
668 | re-flare | 1 |
669 | redox-reactions | 1 |
670 | registration/randomization | 2 |
671 | reosorbilact | 2 |
672 | residronate | 1 |
673 | rgc-res | 1 |
674 | rhil-10 | 3 |
675 | rhmbp-2 | 1 |
676 | rhuil-1ra | 1 |
677 | ribaviron | 1 |
678 | rilotumumab±epirubicin/cisplatin/capecitabine | 1 |
679 | ringkøbing | 1 |
680 | riohacha | 2 |
681 | rivierduinen | 1 |
682 | ro4905417 | 1 |
683 | roussaint | 1 |
684 | rs10811661 | 2 |
685 | rs2705897 | 1 |
686 | rs2724635 | 1 |
687 | rs2887284 | 3 |
688 | rs3118570 | 1 |
689 | rs500766 | 1 |
690 | rs5995355 | 2 |
691 | rt002 | 6 |
692 | rvx000222 | 1 |
693 | rxralpha/gamma | 1 |
694 | s-met | 7 |
695 | s-waves | 1 |
696 | s1p2-3 | 1 |
697 | sahar | 2 |
698 | sarfatti | 2 |
699 | scabicides | 1 |
700 | scorched | 6 |
701 | sdf-1αsignaling | 1 |
702 | secalins | 1 |
703 | seleno-proteins | 1 |
704 | self-aggregated | 2 |
705 | self-infection | 1 |
706 | self-processing | 4 |
707 | semenogelin | 1 |
708 | separatrices | 1 |
709 | ser215 | 1 |
710 | serca2a/phospholamban | 1 |
711 | serine105 | 1 |
712 | sessions/patient | 1 |
713 | shamasan | 1 |
714 | sholapur | 1 |
715 | si-screws | 1 |
716 | silver-resistance | 1 |
717 | smart-soup | 1 |
718 | soroosh | 1 |
719 | spd503 | 1 |
720 | species-differences | 1 |
721 | spiro-phosphonylpyrazoline-oxindoles | 1 |
722 | sr2ceo4 | 2 |
723 | sreemangal | 1 |
724 | srif-receptors | 1 |
725 | ssa5 | 3 |
726 | stat92e | 1 |
727 | stent-therapy | 1 |
728 | stentgrafts | 1 |
729 | sterotypies | 1 |
730 | sti/rtis | 2 |
731 | streptocephalidae | 1 |
732 | stw5/iberogast | 1 |
733 | submarining | 1 |
734 | sulfamates | 1 |
735 | sulfhydryl-compounds | 1 |
736 | sulpirde | 2 |
737 | summands | 1 |
738 | superionicity | 1 |
739 | sv2 | 1 |
740 | symphills | 1 |
741 | synecdoche | 1 |
742 | syphilis-especially | 1 |
743 | szkjy | 1 |
744 | t-3-bpnps | 1 |
745 | t-regulators | 1 |
746 | tab2 | 2 |
747 | tacticity | 1 |
748 | tamrabhasma | 4 |
749 | tasase | 1 |
750 | tcam/spirituality | 1 |
751 | tcdg | 1 |
752 | tehuantepec | 1 |
753 | tel1 | 1 |
754 | ter152arg | 1 |
755 | tetra-hidro-cannabinoid | 2 |
756 | th-immunoreactivity | 1 |
757 | th1-cytokines | 1 |
758 | thapring | 5 |
759 | thermo-adaptability | 1 |
760 | thermoelectricity | 2 |
761 | thermoenzymes | 2 |
762 | thiazolopyridine-2-carbonitriles | 1 |
763 | thienopyrindines | 1 |
764 | thr567 | 1 |
765 | thread-moxa | 1 |
766 | tim-3/tim-1 | 1 |
767 | tnf-alpha-blockers | 2 |
768 | tnf-inhibitors | 1 |
769 | tokombéré | 1 |
770 | totopara | 2 |
771 | toxic-elements | 1 |
772 | toxoplamosis | 1 |
773 | trans-1,3-pentadiene | 4 |
774 | treatment-to-delivery | 1 |
775 | triarylpyrrolines | 1 |
776 | tribendimdine | 3 |
777 | trichomonasis | 4 |
778 | triglycerides/cholesterol | 2 |
779 | troglostrongylosis | 1 |
780 | tsrds | 4 |
781 | tubificidae | 8 |
782 | tumkur | 1 |
783 | turku-loimaa | 2 |
784 | txb2/6-k-pgf1alpha | 3 |
785 | unimportance | 1 |
786 | uninsurance | 3 |
787 | unthealth | 1 |
788 | upmilk | 1 |
789 | up—finally | 1 |
790 | urates | 1 |
791 | ureases | 1 |
792 | users-relatives | 1 |
793 | uti/symptoms | 1 |
794 | uv-level | 1 |
795 | vaccine-hpiv3 | 1 |
796 | vaccinetherapy | 1 |
797 | val32met | 1 |
798 | valp | 1 |
799 | variability/uncertainty | 1 |
800 | vaso-regulation | 2 |
801 | vce-use | 1 |
802 | vegf-a/c/d | 2 |
803 | veillard | 1 |
804 | venlocity | 1 |
805 | ves-odt | 5 |
806 | videodermatoscopy | 1 |
807 | vidofludimus | 5 |
808 | vim-38 | 2 |
809 | vitespan | 1 |
810 | vldl-synthesis | 1 |
811 | volociximab | 1 |
812 | vpes | 3 |
813 | vvgols1 | 4 |
814 | warfarization | 1 |
815 | wireworms | 2 |
816 | wood/food | 1 |
817 | worker-motivation | 1 |
818 | wr-ai1 | 2 |
819 | wu-variability | 1 |
820 | yaba-users | 1 |
821 | zf-3-ost-4 | 1 |
822 | zinc-neutralization | 1 |
823 | znbr2 | 1 |
824 | ~650,000 | 1 |
825 | £14,618 | 1 |
826 | £3488.3 | 1 |
827 | £388,719 | 1 |
828 | ¹²³i-adam | 2 |
829 | ¹³co₂ | 7 |
830 | α-thalassaemia | 2 |
831 | α-thalassaemias | 2 |
832 | α9-nachrs | 1 |
833 | αpkc | 12 |
834 | αtnf-blockers | 1 |
835 | β-interferon | 1 |
836 | β-lysine | 1 |
837 | β2agonists | 1 |
838 | γ-12:1 | 1 |
839 | ε-nh2 | 1 |
840 | π-character | 1 |
841 | π-systems | 2 |
842 | €11,438/qaly | 1 |
843 | €3434/qaly | 1 |
844 | €581 | 1 |
845 | €59.08 | 1 |
846 | €635 | 1 |
847 | ≈eightfold | 1 |
848 | ≤1.20 | 1 |
849 | ≥1:32 | 2 |
850 | ≥285 | 3 |
1 | 5.1-1.0 | 1 |
2 | 41.9±7.0 | 1 |
3 | 37.1±9.0 | 1 |
4 | 10/100,000 | 2 |
5 | ~650,000 | 1 |
6 | 10-15/1000 | 1 |
7 | 605,900 | 1 |
8 | hil-10 | 1 |
9 | rhil-10 | 3 |
10 | ≤1.20 | 1 |
11 | ca130 | 8 |
12 | asn330 | 1 |
13 | opr-150 | 1 |
14 | anti-hsp-60 | 1 |
15 | 2.01-3.60 | 1 |
16 | cs-1170 | 6 |
17 | rs3118570 | 1 |
18 | ev71-hsp90 | 1 |
19 | met90 | 1 |
20 | pre-beta0 | 2 |
21 | tim-3/tim-1 | 1 |
22 | 5.7+/-1.1 | 1 |
23 | 634.1 | 1 |
24 | 43.7±7.1 | 1 |
25 | dpb1*0501 | 1 |
26 | gαq/11 | 2 |
27 | ccl19/21 | 1 |
28 | ly2886721 | 3 |
29 | 19,731 | 3 |
30 | 9-ing-41 | 2 |
31 | rs10811661 | 2 |
32 | 99,961 | 1 |
33 | €581 | 1 |
34 | 8881 | 2 |
35 | γ-12:1 | 1 |
36 | 2-2.5:1 | 1 |
37 | 2.8:1 | 2 |
38 | lactate/hca1 | 1 |
39 | agtrpa1 | 2 |
40 | gmgamyb1 | 1 |
41 | ecd1 | 1 |
42 | paaf1 | 1 |
43 | wr-ai1 | 2 |
44 | tel1 | 1 |
45 | vvgols1 | 4 |
46 | erk-1/-2 | 1 |
47 | nectin-1/-2 | 1 |
48 | blavim-2 | 1 |
49 | rhmbp-2 | 1 |
50 | 3.8-4.2 | 1 |
51 | munc18-1/2 | 1 |
52 | rt002 | 6 |
53 | cnv1014802 | 2 |
54 | pf-04605412 | 2 |
55 | adamts12 | 2 |
56 | rvx000222 | 1 |
57 | gmhsp22 | 1 |
58 | ≥1:32 | 2 |
59 | msp142 | 3 |
60 | 0.9742 | 1 |
61 | org10172 | 1 |
62 | 65.82 | 1 |
63 | tab2 | 2 |
64 | cyp2d2 | 1 |
65 | ε-nh2 | 1 |
66 | cerl2 | 5 |
67 | znbr2 | 1 |
68 | sv2 | 1 |
69 | s1p2-3 | 1 |
70 | gelectin-3 | 1 |
71 | higfbp-3 | 1 |
72 | gs-3 | 1 |
73 | £3488.3 | 1 |
74 | 3,103 | 2 |
75 | isu303 | 2 |
76 | spd503 | 1 |
77 | il-17/il-23 | 1 |
78 | anti-il12/23 | 1 |
79 | 51,523 | 1 |
80 | pph-33 | 1 |
81 | nxf3 | 8 |
82 | crmpk3 | 6 |
83 | baruo3 | 1 |
84 | vaccine-hpiv3 | 1 |
85 | gsk-3/zw3 | 1 |
86 | ige/il-4 | 1 |
87 | zf-3-ost-4 | 1 |
88 | evp-6124 | 5 |
89 | ebv/p24 | 1 |
90 | gsk315234 | 7 |
91 | 0.72-0.74 | 1 |
92 | rs2887284 | 3 |
93 | d19s884 | 1 |
94 | 5100a4 | 1 |
95 | acra4 | 3 |
96 | ld4 | 1 |
97 | sr2ceo4 | 2 |
98 | g7minigp4 | 1 |
99 | catft4 | 2 |
100 | nbtft4 | 1 |
101 | 325.8+14.5 | 1 |
102 | 31.4±14.5 | 1 |
103 | serine105 | 1 |
104 | ser215 | 1 |
105 | c-425 | 9 |
106 | rs2724635 | 1 |
107 | €635 | 1 |
108 | 4.935 | 1 |
109 | rs5995355 | 2 |
110 | 51,965 | 1 |
111 | pound323.85 | 1 |
112 | ≥285 | 3 |
113 | 6+/-0.95 | 1 |
114 | 0.7195 | 1 |
115 | ssa5 | 3 |
116 | jna-ud-6 | 4 |
117 | 0.744+/-0.06 | 1 |
118 | fx06 | 1 |
119 | 95,816 | 1 |
120 | 31,626 | 1 |
121 | 1917-1926 | 1 |
122 | rs500766 | 1 |
123 | n=1186 | 2 |
124 | pat-sm6 | 4 |
125 | phosphotyrosine-stat6 | 1 |
126 | 29.3±5.7 | 1 |
127 | lb80331/lb80317 | 2 |
128 | ro4905417 | 1 |
129 | c9-c17 | 1 |
130 | p257 | 1 |
131 | thr567 | 1 |
132 | rs2705897 | 1 |
133 | €59.08 | 1 |
134 | 4,418 | 1 |
135 | £14,618 | 1 |
136 | psb28 | 3 |
137 | vim-38 | 2 |
138 | 0.94-2.38 | 1 |
139 | 37.6±7.9 | 1 |
140 | £388,719 | 1 |
141 | 1.71-1.99 | 1 |
142 | myl9 | 1 |
143 | hif-α/vegf-a | 1 |
144 | d124a | 1 |
145 | il-17/il-17a | 1 |
146 | r354a/s358a | 1 |
147 | turku-loimaa | 2 |
148 | 45ca | 1 |
149 | probiotica | 1 |
150 | beida | 1 |
151 | 10-250kda | 1 |
152 | coccoidea | 1 |
153 | dypnoea | 1 |
154 | riohacha | 2 |
155 | txb2/6-k-pgf1alpha | 3 |
156 | dysgeucia | 1 |
157 | cerebroplegia | 1 |
158 | nmmhc-iia | 1 |
159 | chokchokia | 1 |
160 | eosinophillia | 1 |
161 | bilirubinaemia | 1 |
162 | α-thalassaemia | 2 |
163 | nec/septicemia | 1 |
164 | pseudohyperkalemia | 1 |
165 | aceruloplasminemia | 2 |
166 | ammonemia | 1 |
167 | alixetimia | 1 |
168 | koupela | 1 |
169 | 0.5ma | 1 |
170 | guelma | 1 |
171 | rxralpha/gamma | 1 |
172 | fiborsarcoma | 1 |
173 | goma | 1 |
174 | cervicocarcinoma | 1 |
175 | hepotoma | 1 |
176 | tamrabhasma | 4 |
177 | guayana | 1 |
178 | gata-3mrna | 1 |
179 | caspase-3mrna | 1 |
180 | ichthyofauna | 2 |
181 | 40gpa | 2 |
182 | 850mpa | 2 |
183 | 169yb-dtpa | 9 |
184 | 113min-dtpa | 5 |
185 | rhuil-1ra | 1 |
186 | totopara | 2 |
187 | mastigophora | 1 |
188 | fitc-bsa | 1 |
189 | ghcesa | 1 |
190 | bonavita | 1 |
191 | thread-moxa | 1 |
192 | hsfa1a/hsfa1b | 2 |
193 | rab5b | 2 |
194 | volociximab | 1 |
195 | inflximab | 1 |
196 | lampalizumab | 1 |
197 | 1.83mb | 1 |
198 | pas-c | 1 |
199 | galecti-3c | 1 |
200 | gal-galnac | 8 |
201 | tehuantepec | 1 |
202 | αpkc | 12 |
203 | nifeviroc | 3 |
204 | lonipc | 3 |
205 | lmcrc | 2 |
206 | has-bled/chads2/cha2ds2-vasc | 2 |
207 | 1368insc | 2 |
208 | 22±2ºc | 1 |
209 | interferon-d | 2 |
210 | vegf-a/c/d | 2 |
211 | scorched | 6 |
212 | self-aggregated | 2 |
213 | ad5.sstr/tk.rgd | 5 |
214 | tetra-hidro-cannabinoid | 2 |
215 | ed-mild | 1 |
216 | 3.31-fold | 1 |
217 | 6-7-fold | 1 |
218 | ≈eightfold | 1 |
219 | hemorrhage-and | 1 |
220 | wood/food | 1 |
221 | ala/sod | 1 |
222 | veillard | 1 |
223 | engord | 1 |
224 | bojnord | 1 |
225 | ommoord | 2 |
226 | -2.4sd | 1 |
227 | asd/ptsd | 1 |
228 | p53-ntd | 2 |
229 | stat92e | 1 |
230 | tubificidae | 8 |
231 | streptocephalidae | 1 |
232 | mimividae | 1 |
233 | gorgoniaceae | 1 |
234 | distress/avoidance | 1 |
235 | radioguidance | 1 |
236 | concordance/discordance | 1 |
237 | age/appearance | 1 |
238 | uninsurance | 3 |
239 | unimportance | 1 |
240 | pyrethroid-resistance | 1 |
241 | silver-resistance | 1 |
242 | co-dependence | 1 |
243 | dependence-independence | 1 |
244 | cladocroce | 3 |
245 | 2.54cm/decade | 1 |
246 | pregrade | 2 |
247 | mitrapide | 1 |
248 | sulpirde | 2 |
249 | n-alkyl-2-aryl-indole-3-carbaldehyde | 1 |
250 | fiche | 1 |
251 | synecdoche | 1 |
252 | chpla2-iie | 1 |
253 | past-stroke | 1 |
254 | hydrocele/spermatocele | 1 |
255 | 3-spiro-1,2-dihydropyrrolooxazine-5,7-dione-oxindole | 1 |
256 | 1-methoxy-indole-3-carbinole | 1 |
257 | laevo-ornidazole | 7 |
258 | amino-benzothiazole | 1 |
259 | constantinople | 1 |
260 | advantame | 3 |
261 | pain/time | 1 |
262 | cytostome | 1 |
263 | 3-minopropyltriethoxysilane | 1 |
264 | 15-f2alpha-isoprostane | 3 |
265 | 4-ene | 1 |
266 | trans-1,3-pentadiene | 4 |
267 | cis-1,3-butadiene | 2 |
268 | polyphenylene | 3 |
269 | all-trans-beta-carotene | 8 |
270 | rilotumumab±epirubicin/cisplatin/capecitabine | 1 |
271 | beta-aspartylglycine | 1 |
272 | 3-aminopyrrolidine | 1 |
273 | 2-substituted-3-sulfonylaminopyridine | 1 |
274 | 2,4,6-triazido-3-chloro-5-fluoropyridine | 1 |
275 | tribendimdine | 3 |
276 | metformin-sibutramine | 1 |
277 | dyhydroergotamine | 1 |
278 | lerkanidipine | 1 |
279 | l-α-lysine | 2 |
280 | β-lysine | 1 |
281 | hydroxylysine | 3 |
282 | fluoxetine/norfluoxetine | 2 |
283 | bucinnazine | 3 |
284 | 2,3-dichloropyrazine | 1 |
285 | 1-hepten-3-one | 1 |
286 | 3-ethoxymethyl-1,4-dihydroquinolin-4-one | 2 |
287 | 4,4'-dihydroxy-2'6'-dimethoxydihydrochalcone | 1 |
288 | 5-hydroxypropafenone | 1 |
289 | piogliazone | 1 |
290 | re-flare | 1 |
291 | blinding.there | 2 |
292 | back-pressure | 2 |
293 | alpha-l-fucosidase | 1 |
294 | aba-8'-hydroxylase | 1 |
295 | exo-β-1,3-galactanase | 3 |
296 | tasase | 1 |
297 | psa-use | 1 |
298 | vce-use | 1 |
299 | glycerate-1,3-bisphosphate | 1 |
300 | monothioarsenate | 4 |
301 | residronate | 1 |
302 | 18-hydroxyeicosapentaenoate | 1 |
303 | lithium+valproate | 1 |
304 | fluoroapetite | 1 |
305 | cyrilovite | 7 |
306 | f₀-value | 1 |
307 | guediawaye | 1 |
308 | dysport/eye | 1 |
309 | kolff | 1 |
310 | lvsd/hf | 6 |
311 | 0.46±0.02g/g | 1 |
312 | 0.6μg/g | 1 |
313 | 61emu/g | 1 |
314 | maxsar10g | 2 |
315 | 19-phenyl-dmag | 1 |
316 | tcdg | 1 |
317 | protein/igg | 1 |
318 | 0.4kg | 1 |
319 | -0.9kg | 1 |
320 | qi-blood-yin-yang | 1 |
321 | ringkøbing | 1 |
322 | arc-welding | 3 |
323 | luciferase-refolding | 1 |
324 | her3-imaging | 1 |
325 | enos-signaling | 1 |
326 | sdf-1αsignaling | 1 |
327 | submarining | 1 |
328 | thapring | 5 |
329 | self-processing | 4 |
330 | bleeding-culminating | 1 |
331 | azd3480-resulting | 1 |
332 | ter152arg | 1 |
333 | prescription/drug | 1 |
334 | h1h | 1 |
335 | dys14/gapdh | 2 |
336 | hypergraph | 1 |
337 | soroosh | 1 |
338 | unthealth | 1 |
339 | lc3b-ii/i | 2 |
340 | q226i | 1 |
341 | erwadi | 1 |
342 | pohnpei | 1 |
343 | lubumbashi | 1 |
344 | p.jirovecii | 2 |
345 | kuppaimeni | 1 |
346 | r.mori | 1 |
347 | sarfatti | 2 |
348 | ccm-3·stripak | 1 |
349 | osnabrueck | 2 |
350 | upmilk | 1 |
351 | 0.13μg/l | 1 |
352 | 0.04-0.45μg/l | 1 |
353 | gh14-3-3l | 2 |
354 | p89l | 1 |
355 | sreemangal | 1 |
356 | ilbl | 1 |
357 | 18.3mg/dl | 1 |
358 | uv-level | 1 |
359 | 40mug/ml | 1 |
360 | 0.0300-15.0μg/ml | 1 |
361 | ethinl-estradiol | 1 |
362 | esterified-cholesterol | 1 |
363 | bs/cholesterol | 1 |
364 | triglycerides/cholesterol | 2 |
365 | paracalcitol | 5 |
366 | l-quebrachitol | 4 |
367 | 4-hydroxycarbazol | 1 |
368 | clilostazol | 1 |
369 | fentaryl | 1 |
370 | c2gnt-m | 4 |
371 | ¹²³i-adam | 2 |
372 | 2'chlordesmethyldiazepam | 1 |
373 | pipercillin/tazobactam | 1 |
374 | echo-exam | 1 |
375 | bereztem | 3 |
376 | 7-10mm | 2 |
377 | 200-400nm | 2 |
378 | 450-700nm | 1 |
379 | 440nm | 1 |
380 | 6.4±2.5nm | 1 |
381 | 0.8nm | 1 |
382 | hydrodynamism | 1 |
383 | mediterraneanism | 1 |
384 | parkisonism | 1 |
385 | polypartnerism | 1 |
386 | agrammatism | 1 |
387 | progressivism | 1 |
388 | post-positivism | 1 |
389 | pseudopterygium | 1 |
390 | neptunium | 1 |
391 | carboplatinum/cisplatinum | 1 |
392 | 100μm×100μm | 1 |
393 | 0.52μm | 1 |
394 | 18.4μm | 1 |
395 | 1.6μm | 1 |
396 | serca2a/phospholamban | 1 |
397 | agratroban | 1 |
398 | behbahan | 1 |
399 | mexico-tenochtitlan | 2 |
400 | vitespan | 1 |
401 | methanofuran | 3 |
402 | shamasan | 1 |
403 | alterationsseen | 1 |
404 | 4'-hydroxyflurbiprofen | 2 |
405 | rivierduinen | 1 |
406 | norrbotten | 1 |
407 | hematocrit/hemoglobin | 1 |
408 | pyraoxystrobin | 3 |
409 | cisplatin/doxorubicin | 1 |
410 | ceftriaxone-vancomycin | 2 |
411 | clairthromycin | 1 |
412 | 7'-demethoxypurpuromycin | 1 |
413 | semenogelin | 1 |
414 | chimaphilin | 5 |
415 | 50°c/min | 1 |
416 | 5-20k/min | 1 |
417 | 40-50l/min | 1 |
418 | 15-60l/min | 1 |
419 | gastrodigenin | 7 |
420 | aloglipin | 1 |
421 | aliskerin | 2 |
422 | oxaliplatin/5-fluorouracil/leucovorin | 1 |
423 | oxaliplatin/fluorouracil/leucovorin | 1 |
424 | l-opsin | 1 |
425 | raltitrexed-oxaliplatin | 1 |
426 | cetuximab/paclitaxel/carboplatin | 1 |
427 | fraxetin | 8 |
428 | lovastotin | 1 |
429 | lumiflavin | 1 |
430 | inter-region | 2 |
431 | conversion/reversion | 1 |
432 | impella-2.5-application | 1 |
433 | deoxidation | 1 |
434 | glutathione-conjugation | 1 |
435 | ach-vasodilation | 1 |
436 | vaso-regulation | 2 |
437 | de-acclimation | 1 |
438 | lung-inflammation | 1 |
439 | cross-combination | 1 |
440 | melamine-contamination | 1 |
441 | consternation | 2 |
442 | polyunsaturation | 1 |
443 | deinstitutionalisation | 2 |
444 | ppargamma-activation | 1 |
445 | life-cultivation | 1 |
446 | worker-motivation | 1 |
447 | zinc-neutralization | 1 |
448 | registration/randomization | 2 |
449 | warfarization | 1 |
450 | positive-reaction | 1 |
451 | self-infection | 1 |
452 | depression-detection | 1 |
453 | nondetection | 5 |
454 | immunodysfunction | 1 |
455 | macroinfarction | 1 |
456 | meaning-construction | 1 |
457 | immuno-nutrition | 1 |
458 | cv-prevention | 2 |
459 | antinocecieption | 1 |
460 | β-interferon | 1 |
461 | ribaviron | 1 |
462 | hampton | 4 |
463 | mfsn | 1 |
464 | bianqueyun | 2 |
465 | mva-5t4/placebo | 1 |
466 | innuendo | 2 |
467 | ciiio | 1 |
468 | kosko | 1 |
469 | appliance.no | 1 |
470 | inos/no | 1 |
471 | pc-acro | 1 |
472 | 8132euro | 1 |
473 | bebedouro | 2 |
474 | adapto | 1 |
475 | carão | 1 |
476 | fe-s-p | 1 |
477 | 18bp | 1 |
478 | one-eye-sleep | 1 |
479 | ace/nep | 1 |
480 | pdhp | 1 |
481 | atskip | 1 |
482 | valp | 1 |
483 | carboxy-hmp | 2 |
484 | hsf1/hsp | 1 |
485 | ca-atp | 1 |
486 | smart-soup | 1 |
487 | metacinnabar | 4 |
488 | 3/1,000/year | 1 |
489 | sahar | 2 |
490 | glutamate/cr | 2 |
491 | anti-mdr | 1 |
492 | coping-together | 8 |
493 | π-character | 1 |
494 | metal/cofactor | 1 |
495 | death/mi/ur | 1 |
496 | tumkur | 1 |
497 | sholapur | 1 |
498 | pawr | 4 |
499 | nk₃r | 1 |
500 | 5.45cm/s | 1 |
501 | 2.68cm/s | 1 |
502 | 90°/s | 1 |
503 | hsp/hsc70s | 1 |
504 | p42s | 1 |
505 | cis-cgas | 1 |
506 | α-thalassaemias | 2 |
507 | dl-las | 2 |
508 | eyas | 3 |
509 | cd11cdcs | 2 |
510 | alpha-lithics | 4 |
511 | hypolipidaemics | 4 |
512 | phytotherapics | 1 |
513 | beta2-mimetics | 1 |
514 | cannabimimetics | 2 |
515 | dopaminomimetics | 1 |
516 | probiotics/synbiotics | 4 |
517 | pharmacodiagnostics | 1 |
518 | paralytics | 1 |
519 | 11-ocs | 1 |
520 | mmscs | 2 |
521 | fcds | 2 |
522 | anisakids | 2 |
523 | mylagaulids | 1 |
524 | cni/steroids | 1 |
525 | poroids | 1 |
526 | acubands | 2 |
527 | summands | 1 |
528 | knee-bends | 1 |
529 | 'trends | 2 |
530 | sulfhydryl-compounds | 1 |
531 | lipds | 1 |
532 | tsrds | 4 |
533 | flavonoïds | 1 |
534 | fistulaes | 1 |
535 | questions/probes | 1 |
536 | obesity-indices | 1 |
537 | separatrices | 1 |
538 | species-differences | 1 |
539 | scabicides | 1 |
540 | dip-slides | 4 |
541 | 2-oxo-1,2,3,4-tetrahydroquinoline-3-carboxamides | 1 |
542 | ginsensides | 1 |
543 | flavonoid-glycosides | 1 |
544 | asialogangliosides | 1 |
545 | nonapeptides | 1 |
546 | phytonematodes | 1 |
547 | 2-bromobenzaldehydes | 2 |
548 | drainages | 24 |
549 | e-technologies | 1 |
550 | micro-colonies | 3 |
551 | sterotypies | 1 |
552 | atypicalities | 1 |
553 | fidelities | 4 |
554 | combustion-derived-nanoparticles | 1 |
555 | hydrocoeles | 5 |
556 | thiazolopyridine-2-carbonitriles | 1 |
557 | spiro-phosphonylpyrazoline-oxindoles | 1 |
558 | 3-indolyl-3-aminooxindoles | 1 |
559 | 4-aryl-nh-1,2,3-triazoles | 2 |
560 | 3-hydroxy-3-trifluoromethylpyrazoles | 1 |
561 | injectisomes | 1 |
562 | lpmes | 3 |
563 | thermoenzymes | 2 |
564 | allylsilanes | 3 |
565 | leucotrienes | 2 |
566 | 2-alkylazaarenes | 1 |
567 | 3-ethoxycarbonyl-1-aza-9-oxafluorenes | 1 |
568 | dispirooxindolopyrrolidines | 1 |
569 | 3-azidopiperidines | 1 |
570 | pyrrolizidines | 3 |
571 | thienopyrindines | 1 |
572 | neurotrophines | 1 |
573 | th1-cytokines | 1 |
574 | triarylpyrrolines | 1 |
575 | 1,3-nitroamines | 1 |
576 | 2-acyl-1-hydroxy-2,3,1-diazaborines | 1 |
577 | 4-aminoantipyrines | 1 |
578 | 7-substituted-3-methyl-quinoxalin-2-ones | 1 |
579 | 2-aminophenoxazin-3-ones | 1 |
580 | imidazothioxanthones | 2 |
581 | 3-hydroxy-2,3-dihydroisoquinoline-1,4-diones | 1 |
582 | 1,2,4-triazole-3-thiones | 1 |
583 | 3-coumaranones | 2 |
584 | benzopyrones | 1 |
585 | phosphono-γ-butyrolactones | 1 |
586 | 3,5-dien-1-ynes | 2 |
587 | psychotropes | 2 |
588 | vpes | 3 |
589 | mutations/haplotypes | 1 |
590 | patho-phenotypes | 1 |
591 | rgc-res | 1 |
592 | melanospheres | 1 |
593 | empires | 1 |
594 | micropores | 18 |
595 | clamidospores | 1 |
596 | carpospores | 1 |
597 | ureases | 1 |
598 | deseases | 3 |
599 | glutaminases | 2 |
600 | alkalinephophatases | 1 |
601 | longhouses | 1 |
602 | polymorphonucleates | 2 |
603 | photosynthates | 2 |
604 | 8-plates | 2 |
605 | sulfamates | 1 |
606 | dichromates | 1 |
607 | urates | 1 |
608 | fetes | 1 |
609 | hemophagocytes | 1 |
610 | ldl-cholesterol-values | 1 |
611 | abeta-plaques | 1 |
612 | s-waves | 1 |
613 | users-relatives | 1 |
614 | phenyhydrazone-derivatives | 1 |
615 | crhsfs | 1 |
616 | chest-findings | 1 |
617 | dbhs | 2 |
618 | chlorophototrophs | 1 |
619 | arbs/aceis | 1 |
620 | outcomes.this | 2 |
621 | trichomonasis | 4 |
622 | capsulodesis | 3 |
623 | vldl-synthesis | 1 |
624 | pheromonogenesis | 1 |
625 | iatrogenesis | 9 |
626 | pruritogenesis | 1 |
627 | megacalycosis | 3 |
628 | ashworthiosis | 2 |
629 | franciselliosis | 1 |
630 | metallosis | 3 |
631 | edwardsiellosis | 1 |
632 | bartonellosis | 2 |
633 | troglostrongylosis | 1 |
634 | toxoplamosis | 1 |
635 | paramphistomosis | 2 |
636 | molybdenosis | 1 |
637 | depression-diagnosis | 1 |
638 | otodectosis | 1 |
639 | glossoptosis | 1 |
640 | colpo-cervicitis | 1 |
641 | hemocolitis | 1 |
642 | pan-vasculitis | 1 |
643 | plm-to-lymphadenitis | 1 |
644 | sti/rtis | 2 |
645 | de-novo-utis | 2 |
646 | pcutis | 1 |
647 | itks | 1 |
648 | maguks | 1 |
649 | oh-radicals | 1 |
650 | biradicals | 1 |
651 | glycals | 1 |
652 | fdls | 6 |
653 | eigenchannels | 1 |
654 | beta-barrels | 1 |
655 | mmp-2-levels | 1 |
656 | pgrn+cells | 2 |
657 | symphills | 1 |
658 | basic-skills | 1 |
659 | 1,4-diyn-3-ols | 1 |
660 | amphenicols | 8 |
661 | 1,2-diarylethanols | 1 |
662 | phytosterols/-stanols | 4 |
663 | ees/bms | 1 |
664 | π-systems | 2 |
665 | uti/symptoms | 1 |
666 | wireworms | 2 |
667 | lungworms | 1 |
668 | asms | 2 |
669 | phyto-anti-oestrogens | 1 |
670 | chemoregimens | 1 |
671 | seleno-proteins | 1 |
672 | secalins | 1 |
673 | blepharismins | 1 |
674 | pterins | 1 |
675 | akirins | 2 |
676 | pseudoerosions | 1 |
677 | ambulations | 2 |
678 | deletions/mutations | 1 |
679 | redox-reactions | 1 |
680 | co-detections | 1 |
681 | ct-reconstructions | 2 |
682 | photoelectrons | 1 |
683 | pill-placebos | 1 |
684 | igg-anti-lps | 1 |
685 | t-3-bpnps | 1 |
686 | r-btps | 1 |
687 | flareups | 1 |
688 | gaba-b-rs | 1 |
689 | crf2rs | 3 |
690 | tnf-alpha-blockers | 2 |
691 | αtnf-blockers | 1 |
692 | beta-adrenoceptor-blockers | 1 |
693 | oilworkers | 1 |
694 | 21-22-mers | 1 |
695 | foragers-farmers | 1 |
696 | yaba-users | 1 |
697 | α9-nachrs | 1 |
698 | endoanchors | 7 |
699 | inflammatory-mediators | 1 |
700 | t-regulators | 1 |
701 | k-factors | 1 |
702 | che-inhibitors | 1 |
703 | tnf-inhibitors | 1 |
704 | beta-1-receptors | 1 |
705 | 5ht3-receptors | 1 |
706 | srif-receptors | 1 |
707 | korean-ness | 1 |
708 | information/awareness | 1 |
709 | mechano-responsiveness | 1 |
710 | non-directiveness | 2 |
711 | meaninglessness | 4 |
712 | expertness | 1 |
713 | mmpss | 1 |
714 | lactose-adducts | 1 |
715 | cgg-triplets | 1 |
716 | stentgrafts | 1 |
717 | herbs/plants | 2 |
718 | helleborus-implants | 2 |
719 | toxic-elements | 1 |
720 | nanoelements | 1 |
721 | am-treatments | 1 |
722 | m-components | 2 |
723 | double-j-stents | 1 |
724 | gamma-mpts | 1 |
725 | plant-parts | 5 |
726 | amastigote/nests | 1 |
727 | β2agonists | 1 |
728 | periodontists | 2 |
729 | chorioangiopagus | 1 |
730 | vidofludimus | 5 |
731 | arbovirus | 6 |
732 | si-screws | 1 |
733 | plows | 1 |
734 | bps/pathways | 1 |
735 | lys-lys | 1 |
736 | aml/at | 1 |
737 | damp-beat | 1 |
738 | deat | 1 |
739 | cho/protein/fat | 1 |
740 | bavanat | 1 |
741 | reosorbilact | 2 |
742 | defct | 1 |
743 | 3,6-dt | 1 |
744 | ves-odt | 5 |
745 | s-met | 7 |
746 | val32met | 1 |
747 | f-18-fdg-pet | 1 |
748 | 18f-fdg-pet | 2 |
749 | mr-ht | 1 |
750 | neuro-deficit | 1 |
751 | gilgit | 1 |
752 | metal/contaminant | 1 |
753 | sessions/patient | 1 |
754 | oat-supplement | 1 |
755 | bg-involvement | 1 |
756 | disruption-replenishment | 1 |
757 | nonconsent | 1 |
758 | multi-constituent | 3 |
759 | roussaint | 1 |
760 | lbpt | 2 |
761 | impella-2.5-support | 1 |
762 | stw5/iberogast | 1 |
763 | inter-est | 3 |
764 | interest | 8,035 |
765 | importance/interest | 1 |
766 | baby-bust | 1 |
767 | interferon-tau | 1 |
768 | gdu | 5 |
769 | cangzhou | 1 |
770 | exu | 1 |
771 | 44.05ev | 1 |
772 | psp/lvesv | 4 |
773 | non-iw | 1 |
774 | oirsiw | 4 |
775 | curassow | 4 |
776 | na-h275y | 1 |
777 | kalasugay | 1 |
778 | leeway | 5 |
779 | control/self-efficacy | 4 |
780 | itineracy | 1 |
781 | insurgency | 2 |
782 | 75-78gy | 1 |
783 | 100-300kgy | 1 |
784 | ecotechnology | 1 |
785 | neuroimmunology | 2 |
786 | herpetology | 2 |
787 | phytosynergy | 1 |
788 | patriarchy | 1 |
789 | exooceanography | 1 |
790 | macrovasculopathy | 2 |
791 | szkjy | 1 |
792 | €3434/qaly | 1 |
793 | €11,438/qaly | 1 |
794 | physiologists-notably | 1 |
795 | atropselectively | 1 |
796 | syphilis-especially | 1 |
797 | up—finally | 1 |
798 | homogamy | 5 |
799 | 'harmony | 1 |
800 | gastricatony | 1 |
801 | stent-therapy | 1 |
802 | vaccinetherapy | 1 |
803 | pharmachotherapy | 1 |
804 | autostereoscopy | 1 |
805 | videodermatoscopy | 1 |
806 | friary | 1 |
807 | extracellulary | 1 |
808 | treatment-to-delivery | 1 |
809 | impedancemetry | 1 |
810 | pseudosymmetry | 2 |
811 | fluorospectrophotometry | 3 |
812 | bettolepsy | 4 |
813 | metallicity | 4 |
814 | iatrogenicity | 1 |
815 | superionicity | 1 |
816 | thermoelectricity | 2 |
817 | tacticity | 1 |
818 | venlocity | 1 |
819 | he-terogeneity | 1 |
820 | artificiality | 1 |
821 | interculturality | 1 |
822 | morbi/mortality | 2 |
823 | tcam/spirituality | 1 |
824 | wu-variability | 1 |
825 | thermo-adaptability | 1 |
826 | comfort/stability | 1 |
827 | neuromaturity | 1 |
828 | barometeosensivity | 2 |
829 | nf-κb-activity | 1 |
830 | m-cholinoreactivity | 1 |
831 | th-immunoreactivity | 1 |
832 | variability/uncertainty | 1 |
833 | kasianowicz | 1 |
834 | glycated-lz | 1 |
835 | ¹³co₂ | 7 |
836 | h₂co₃ | 5 |
837 | multicyte™ | 1 |
838 | fit-2-play™ | 1 |
839 | tokombéré | 1 |
840 | fillerina® | 2 |
841 | gralise® | 2 |
842 | gelclair® | 3 |
843 | 0.9°-1.4° | 1 |
844 | 17.4° | 1 |
845 | +1·4° | 1 |
846 | 0.27°±1.75° | 1 |
847 | 182°-186° | 1 |
848 | 25.7° | 1 |
849 | phospho-ikb-α | 1 |
850 | phosphorylated-camkii-α | 1 |